Relief Therapeutics Holding (Relief Therapeutics Holding) Dividends per Share

: $0.00 (TTM As of Jun. 2023)

View and export this data going back to 1990. Start your Free Trial

Relief Therapeutics Holding's dividends per share for the six months ended in Jun. 2023 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2023 was 0.00. As of today, Relief Therapeutics Holding's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Relief Therapeutics Holding Dividends per Share Historical Data

The historical data trend for Relief Therapeutics Holding's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dividends per Share

Get a 7-Day Free Trial

Relief Therapeutics Holding Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison

For the Biotechnology subindustry, Relief Therapeutics Holding's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relief Therapeutics Holding Dividend Yield % Distribution

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Dividend Yield % falls into.

Relief Therapeutics Holding Dividends per Share Calculation

Dividends paid to per common share.

Relief Therapeutics Holding (OTCPK:RLFTF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Relief Therapeutics Holding's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2023 )	/	EPS without NRI (Q: Jun. 2023 )
	=	0	/	-1.084
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Relief Therapeutics Holding Dividends per Share Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (Relief Therapeutics Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTF) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFz:UK RLF:Switzerland

Address

Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.